Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 2.7.1.137 extracted from

  • Kawaguchi, W.; Itamochi, H.; Kigawa, J.; Kanamori, Y.; Oishi, T.; Shimada, M.; Sato, S.; Shimogai, R.; Sato, S.; Terakawa, N.
    Simultaneous inhibition of the mitogen-activated protein kinase kinase and phosphatidylinositol 3-kinase pathways enhances sensitivity to paclitaxel in ovarian carcinoma (2007), Cancer Sci., 98, 2002-2008.
    View publication on PubMed

Inhibitors

Inhibitors Comment Organism Structure
LY294002 simultaneous inhibition of the mitogen-activated protein kinase kinase and phosphatidylinositol 3-kinase pathways enhances sensitivity to paclitaxel in ovarian carcinoma Homo sapiens

Organism

Organism UniProt Comment Textmining
Homo sapiens
-
-
-

Source Tissue

Source Tissue Comment Organism Textmining
ovarian serous adenocarcinoma cell line KF, KFTx, SHIN-3, KOC-2S, and SK-OV-3. Simultaneous inhibition of the mitogen-activated protein kinase kinase and phosphatidylinositol 3-kinase pathways enhances sensitivity to paclitaxel in ovarian carcinoma Homo sapiens
-